MyChoice CDx
NGS-based homologous recombination deficiency companion diagnostic assessing BRCA1/2 and genomic instability in FFPE ovarian tumor tissue.
- Developer
- Myriad Genetics
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- Copy number, DNA mutation
- Current version
- MyChoice CDx P190014/S011 current configuration (2026)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.